Taking people1. fázis
A clinical study to assess if a new investigational medicinal product called JJP-1212 is safe, tolerable and able to induce a specific immune response in humans
Key facts
- Where
- Sofia, BulgáriaSee the site
- Phase
- 1. fázis
Where in Bulgária
- Alexandrovska University HospitalSofia, BulgáriaToborzás még nem indult
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Jjp Biologics Sp. z o.o.
- Trial code
- EU 2023-508661-33-00
- Record updated
- 2026. október 30.